Guardian Therapeutics
Focus: Guardian Therapeutics is a biotechnology company headquartered in Lexington, MA, specializing in aptamer therapeutics across musculoskeletal, neurology, and respiratory indications. The company appears to be in early-stage development with a small clinical footprint.
Profile data last refreshed 13h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Guardian Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Guardian Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
Post-LOE
Post-patent generic with minimal differentiation; not core to company's aptamer strategy.
Help build intelligence for Guardian Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.